Cyclacel Limited (CYCC) Answers Celgene (CELG)'s Declaratory Judgment Complaint and Counterclaims for Infringement of Four Cyclacel Patents
6/18/2010 9:13:42 AM
More...
|
Cyclacel Limited (CYCC) Receives Complaint Filed by Celgene Corporation (CELG) Seeking to Avoid Certain Cyclacel Patents
5/3/2010 10:22:14 AM
More...
|
Cyclacel Limited (CYCC) Announces Publication of Peer-Reviewed Journal Article Describing the Mechanism of Action of Seliciclib
12/30/2009 10:08:36 AM
More...
|
Cyclacel Limited (CYCC) Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 American Society of Hematology Annual Meeting
12/7/2009 8:48:59 AM
More...
|
Cyclacel Limited (CYCC) to Present At Annual Needham Biotechnology and Medical Technology Conference
6/9/2009 9:24:37 AM
More...
|
Cyclacel Limited (CYCC) Advances Oral Sapacitabine Pivotal Trial Plan in Hematological Malignancies
2/6/2009 6:36:29 AM
More...
|
Cyclacel Limited (CYCC) Announces Completion of Enrollment in Phase 2 Trial of Sapacitabine in Elderly AML
10/9/2008 11:12:41 AM
More...
|
Cyclacel Limited (CYCC) to Present at Annual Needham Biotechnology & Medical Technology Conference
6/5/2008 12:58:37 PM
More...
|
Cyclacel Limited (CYCC) Reports Second Quarter 2006 Financial Results
8/15/2006 10:57:50 AM
More...
|
Xcyte Therapies, Inc. Stockholders Approve Transaction With Cyclacel Group plc
3/17/2006 12:27:22 PM
More...
|
|